Langer-inspired Kala files for an $86M IPO; J&J backs Provention Bio
→ Kala Pharmaceuticals has filed for an $86 million IPO, just weeks after the biotech reported positive top line data for a Phase III study …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
